Bridging Borders: CureMeAbroad Raises $600K to Transform Medical Tourism with AI
What is the news?
Pune-based startup CureMeAbroad has successfully closed a $600,000 pre-seed funding round as it seeks to digitize the fragmented medical tourism industry. Founded in June 2025 by Aditya Oza and Mikhail Bohra, the platform addresses a critical gap in international healthcare: the lack of pricing transparency and the reliance on unverified agents. The round saw participation from a group of high-profile angel investors, signaling strong confidence in the startup’s tech-first approach.
Why is it interesting?
CureMeAbroad utilizes a proprietary AI cost estimator trained on over 600 procedure records to help international patients discover the right hospitals and surgeons based on their specific budget and medical needs. With a directory spanning 47 countries and 45 specialties, the platform is rapidly becoming a go-to resource for patients in the UK, US, and GCC looking for affordable, high-quality treatments in hubs like India, Thailand, and Mexico.
The founders, who previously led successful ventures like EMotorad, launched CureMeAbroad after identifying the staggering wait times for non-critical surgeries in Western healthcare systems. This new capital infusion will be deployed to enhance their “multilingual patient intelligence layer” and expand their clinical matching models, further establishing India as a global hub for healthcare innovation.
Read more: Med-tech tourism startup CureMeAbroad raises pre-seed round